Abstract:Objective: To investigate the effect and mechanism of emodin (EMO) on human pancreatic cancer cell line BxPC-3 in vivo. Methods: After the pancreatic cancer model in nude mice was established, the mice were divided into four groups: control group (NS 0.2mL/d by i.p. injection), EMO group (EMO 40mg?kg-1?d-1 by i.p. injection), and Gemcitabine (GEM) group (GEM 80mg/kg, twice/week by i.p. injection) with 8 mice each group. After 2 weeks of administration, the mice were sacrificed, detected the body-weight change of nude nice before and after the experiment, and recorded the growth inhibition rate of tumor (TGI). Immunohistochemical (IHC) staining for ki-67 and terminal deoxynucleotidyl transferase-mediated nicked labeling assay (TUNEL) were undertaken to detect the cell proliferation and cell apoptosis in tumor tissue in xenograft nude mice. Results: The inter-group comparisons in body-weight of nude mice showed no significant difference in comparing group NS(27.0±1.64)g with group EMO(25.1±1.58)g and GEM(25.6± 1.47)g.The EMO group was 38.46%, the GEM group was 44.23%. The inter-group comparisons in immunohistochemical analysis of ki-67 showed significant difference in comparing group NS IOD(219.5±17.98) with group EMO IOD(146.6± 11.57)and GEM IOD(139.5±12.55), (P0.01), and the expression of ki-67 in EMO and GEM groups were lower than that in NS group, P0.05; while the expression of ki-67 between EMO and GEM groups showed no significant difference. The inter-group comparisons in TUNEL analysis showed significant difference in comparing group NS IOD(23.6±6.02) with group EMO IOD(65.7±4.97)and GEM IOD(67.4±5.59), (P0.01), and the TUNEL-positive cells in EMO and GEM groups were higher than that in NS group; while the TUNEL-positive cells between EMO and GEM groups showed no significant difference. Conclusion: Emodin can inhibit the growth of pancreatic cancer cells BXPC-3 in nude mice; and this affection was achieved by suppressing cell proliferation and inducing cell apoptosis.

Cytotoxicity of Gemcitabine-Loaded Albumin Nanoparticles on Human Pancreatic Cancer Cells SW1990 in Vitro

Effect of 406 nm-gemcitabine-loaded albumin nanoparticles on in vitro human pancreatic cancer cells CFPAC-1

Preparation of Bovine Serum Albumin Nanoparticles Loaded with Gemcitabine and the Cytotoxic Effect on Pancreatic Cancer Cells in Vitro

Preparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitro

Gemcitabine-loaded Albumin Nanospheres (Gem-Anps) Inhibit PANC-1 Cells in Vitro and in Vivo

Effect of RGD-conjugated Gemcitabine-Loaded Albumin Nanoparticles on Cell Cycle and Apoptosis of Pancreatic Cancer Cells

Effect of gemcitabine-loaded albumin nanoparticles on the micro-angiogenesis of pancreatic cancer

Study on inhibitory effects of RGD-conjugated gemcitabine-loaded albumin nanoparticles on the proliferation of BxPC-3 cells in vitro

Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in Vitro

Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression.

Anti-tumor Activity of Emodin on Human Pancreatic Cancer Cell Line BXPC-3 in Vivo

Preparation of LyP-1-conjugated multi-walled carbon nanotubes loaded with gemcitabine and their cytotoxicity on human pancreatic cancer cells in vitro

Enzyme-sensitive gemcitabine conjugated albumin nanoparticles as a versatile theranostic nanoplatform for pancreatic cancer treatment

Enhanced Tumor Targeting of Crgd Peptide-Conjugated Albumin Nanoparticles in the BxPC-3 Cell Line.

Preparation, Physicochemical Characterization and Cytotoxicity in Vitro of Gemcitabine-Loaded Peg-Pdlla Nanovesicles

Effect of Gemcitabine on Proliferation, Apoptosis and Polo-Like Kinase-1 Expression of Pancreatic Cancer Cell Line AsPC-1

A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy

In vitro study on gemcitabine carryingg iron-containing magnetic nanoparticles in treating pancreatic carcinoma cells

Human bone marrow mesenchymal stem cell-derived exosomes loaded with gemcitabine inhibit pancreatic cancer cell proliferation by enhancing apoptosis

Gemcitabine-loaded chitosan nanoparticles enhanced apoptotic and ferroptotic response of gemcitabine treatment alone in the pancreatic cancer cells in vitro

Effects of Gemcitabine on Radiosensitization, Apoptosis, and Bcl-2 and Bax Protein Expression in Human Pancreatic Cancer Xenografts in Nude Mice